Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-ZAP70 antibody (286-335 aa) (STJ96296) | Login | Anti-ZAP70 antibody (286-335 aa) (STJ96296) | ||||||||||||||||
|
||||||||||||||||||
Anti-ZDHHC2 antibody (61-110 aa) (STJ96304) | Login | Anti-ZDHHC2 antibody (61-110 aa) (STJ96304) | ||||||||||||||||
|
||||||||||||||||||
Anti-ZNF106 antibody (1833-1882 aa) (STJ96306) | Login | Anti-ZNF106 antibody (1833-1882 aa) (STJ96306) | ||||||||||||||||
|
||||||||||||||||||
Anti-ZMYM4 antibody (801-850 aa) (STJ96324) | Login | Anti-ZMYM4 antibody (801-850 aa) (STJ96324) | ||||||||||||||||
|
||||||||||||||||||
Anti-ZNRF2 antibody (161-210 aa) (STJ96351) | Login | Anti-ZNRF2 antibody (161-210 aa) (STJ96351) | ||||||||||||||||
|
||||||||||||||||||
Anti-CSGALNACT1 antibody (201-250 aa) (STJ96371) | Login | Anti-CSGALNACT1 antibody (201-250 aa) (STJ96371) | ||||||||||||||||
|
||||||||||||||||||
Anti-SLC29A1 antibody (15-64 aa) (STJ96396) | Login | Anti-SLC29A1 antibody (15-64 aa) (STJ96396) | ||||||||||||||||
|
||||||||||||||||||
Anti-GLUL antibody (295-344 aa) (STJ96400) | Login | Anti-GLUL antibody (295-344 aa) (STJ96400) | ||||||||||||||||
|
||||||||||||||||||
Anti-SF3B1 antibody (75-124 aa) (STJ96403) | Login | Anti-SF3B1 antibody (75-124 aa) (STJ96403) | ||||||||||||||||
|
||||||||||||||||||
Anti-MYO6 antibody (40-120 aa) (STJ96437) | Login | Anti-MYO6 antibody (40-120 aa) (STJ96437) | ||||||||||||||||
|
||||||||||||||||||
Anti-SND1 antibody (Internal) (STJ96449) | Login | Anti-SND1 antibody (Internal) (STJ96449) | ||||||||||||||||
|
||||||||||||||||||
Anti-RHCG antibody (Internal) (STJ96453) | Login | Anti-RHCG antibody (Internal) (STJ96453) | ||||||||||||||||
|
||||||||||||||||||
Anti-IL31RA antibody (Internal) (STJ96456) | Login | Anti-IL31RA antibody (Internal) (STJ96456) | ||||||||||||||||
|
||||||||||||||||||
Anti-STRN antibody (C-Term) (STJ96457) | Login | Anti-STRN antibody (C-Term) (STJ96457) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDH6 antibody (180-260 aa) (STJ96476) | Login | Anti-CDH6 antibody (180-260 aa) (STJ96476) | ||||||||||||||||
|
||||||||||||||||||
Anti-CX3CR1 antibody (120-200 aa) (STJ96477) | Login | Anti-CX3CR1 antibody (120-200 aa) (STJ96477) | ||||||||||||||||
|
||||||||||||||||||
Anti-KRAS antibody (150-189 aa) (STJ97704) | Login | Anti-KRAS antibody (150-189 aa) (STJ97704) | ||||||||||||||||
|
||||||||||||||||||
Anti-CXCL8 antibody (C-Term) [13F8] (STJ97717) | Login | Anti-CXCL8 antibody (C-Term) [13F8] (STJ97717) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCNB1 antibody (60-140 aa) [1A5] (STJ97756) | Login | Anti-CCNB1 antibody (60-140 aa) [1A5] (STJ97756) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCNB1 antibody (60-140 aa) [5C1] (STJ97767) | Login | Anti-CCNB1 antibody (60-140 aa) [5C1] (STJ97767) | ||||||||||||||||
|
||||||||||||||||||
Anti-SMAD3 antibody (350-430 aa) [4C9] (STJ97772) | Login | Anti-SMAD3 antibody (350-430 aa) [4C9] (STJ97772) | ||||||||||||||||
|
||||||||||||||||||
Anti-DDIT3 antibody (10-90 aa) [2B1] (STJ97774) | Login | Anti-DDIT3 antibody (10-90 aa) [2B1] (STJ97774) | ||||||||||||||||
|
||||||||||||||||||
Anti-DDIT3 antibody (10-90 aa) [1E1] (STJ97775) | Login | Anti-DDIT3 antibody (10-90 aa) [1E1] (STJ97775) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDH5 antibody (670-750 aa) [8E5] (STJ97779) | Login | Anti-CDH5 antibody (670-750 aa) [8E5] (STJ97779) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPK3 antibody [5E9] (STJ97780) | Login | Anti-MAPK3 antibody [5E9] (STJ97780) | ||||||||||||||||
|